Effect of adjuvant endocrine therapy on recurrence and contralateral breast cancer in HR-positive DCIS after mastectomy

Adjuvant endocrine therapy was associated with significant reductions in recurrence and CBC risk after mastectomy for HR-positive DCIS, supporting selective use based on individual risk assessment.

Institutions

Publication Details

Journal
The Breast
Published
2025-10-01
DOI
https://doi.org/10.1016/j.breast.2025.104615
Primary Topic
Breast Cancer Treatment Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effect of adjuvant endocrine therapy on recurrence and contralateral breast cancer in HR-positive DCIS after mastectomy

The Breast
Breast Cancer Treatment Studies
article

Effect of adjuvant endocrine therapy on recurrence and contralateral breast cancer in HR-positive DCIS after mastectomy

article en

Abstract

Adjuvant endocrine therapy was associated with significant reductions in recurrence and CBC risk after mastectomy for HR-positive DCIS, supporting selective use based on individual risk assessment.

The Breast
Ulsan College (KR), Asan Medical Center (KR), Samsung Medical Center (KR), University of Ulsan (KR), Gangnam Severance Hospital (KR), Dongnam Institute of Radiological & Medical Sciences (KR), Sungkyunkwan University (KR)
Good health and well-being
Openalex Percentile: Top 39%
Breast Cancer Treatment Studies
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.